Nov 19 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS GRANTED PRIORITY REVIEW STATUS FOR GLIOLAN® BY HEALTH CANADA
* MEDEXUS PHARMACEUTICALS INC - ANTICIPATES FILING NDS IN 2019 FOR APPROVAL TO MARKET AND SELL GLIOLAN IN CANADA
Nov 19 (Reuters) - Medexus Pharmaceuticals Inc MDP.V :
* MEDEXUS GRANTED PRIORITY REVIEW STATUS FOR GLIOLAN® BY HEALTH CANADA
* MEDEXUS PHARMACEUTICALS INC - ANTICIPATES FILING NDS IN 2019 FOR APPROVAL TO MARKET AND SELL GLIOLAN IN CANADA